Safety and efficacy of switiching from levetiracetam to brivaracetam in patients with difficult-to-treat partial onset epilepsy

Trial Profile

Safety and efficacy of switiching from levetiracetam to brivaracetam in patients with difficult-to-treat partial onset epilepsy

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs Brivaracetam (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Feb 2017 New trial record
    • 06 Dec 2016 Results presented at the 70th Annual Meeting of the American Epilepsy Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top